Yale University identifies SARS-CoV-2 3C-like proteinase inhibitors
Aug. 4, 2022
Yale University has presented new 3C-like proteinase (3CLpro; Mpro; nsp5) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection.
